Issue 4/2015
Content (5 Articles)
Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
William R. Strohl
Comparative Immunogenicity of TNF Inhibitors: Impact on Clinical Efficacy and Tolerability in the Management of Autoimmune Diseases. A Systematic Review and Meta-Analysis
Sarah S. Thomas, Nabeel Borazan, Nashla Barroso, Lewei Duan, Sara Taroumian, Benjamin Kretzmann, Ricardo Bardales, David Elashoff, Sitaram Vangala, Daniel E. Furst
Cost Effectiveness of Monoclonal Antibody Therapy for Rare Diseases: A Systematic Review
Taehwan Park, Scott K. Griggs, Dong-Churl Suh
How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009–2013
Ylenia Ingrasciotta, Francesco Giorgianni, Jenny Bolcato, Alessandro Chinellato, Roberta Pirolo, Daniele Ugo Tari, Chiara Troncone, Andrea Fontana, Valentina Ientile, Rosa Gini, Domenico Santoro, Mariacarmela Santarpia, Armando Genazzani, Ilaria Uomo, Maurizio Pastorello, Walter Sebastiano Pollina Addario, Salvatore Scondotto, Pasquale Cananzi, Achille Patrizio Caputi, Gianluca Trifirò
An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin
Alessandra Gianoncelli, Sara A. Bonini, Michela Bertuzzi, Michela Guarienti, Sara Vezzoli, Rajesh Kumar, Andrea Delbarba, Andrea Mastinu, Sandra Sigala, Pierfranco Spano, Luca Pani, Sergio Pecorelli, Maurizio Memo